Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-08-004849
Filing Date
2008-03-17
Accepted
2008-03-14 21:45:38
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v37725e10vk.htm 10-K 1462054
2 EXHIBIT 23.1 v37725exv23w1.htm EX-23.1 2252
3 EXHIBIT 31.1 v37725exv31w1.htm EX-31.1 6114
4 EXHIBIT 31.2 v37725exv31w2.htm EX-31.2 6414
5 EXHIBIT 32.1 v37725exv32w1.htm EX-32.1 2899
6 EXHIBIT 32.2 v37725exv32w2.htm EX-32.2 3937
7 GRAPHIC v37725v3772501.gif GRAPHIC 34744
8 GRAPHIC v37725v3772502.gif GRAPHIC 21071
9 GRAPHIC v37725v3772503.gif GRAPHIC 11655
  Complete submission text file 0000950134-08-004849.txt   1578622
Mailing Address 110 - 110TH AVENUE NE SUITE 685 BELLEVUE WA 98004
Business Address 110 - 110TH AVENUE NE SUITE 685 BELLEVUE WA 98004 425-450-0370
Oncothyreon Inc. (Filer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33882 | Film No.: 08691008
SIC: 8731 Services-Commercial Physical & Biological Research